This page shows the latest Dennis O'Brien news and features for those working in and with pharma, biotech and healthcare.
Expands reach in UK, Asia Pacific and Middle East. From left to right: Cliff Wyatt, HealthCare21 managing director, Jan Steele, Lucid Group COO and co-founder and Dennis O’Brien, Lucid ... HealthCare21 brings further scientific and editorial expertise
Bluedog brings a “key piece of the jigsaw” to Lucid, commented Lucid’s CEO Dennis O’Brien, referring to the company’s skills in digital design, motion graphics, video development and ... a “perfect match” says O’Brien.
The best communications programmes start by identifying the patient outcomes they want to improve and work backwards from there,” says Dennis O’Brien, CEO, Lucid Group. ... says Dennis O’Brien.
Lucid's CEO on the Awards' enduring influence
Lucid’s founders Dennis O’Brien and Jan Steele will continue to lead the business. ... O’Brien said: “We felt the time was right to bring on board a strategic partner, and in LDC we have an experienced investor with a strong track record in the
It is hard to do this from the bottom up,” says Dennis O'Brien, CEO, Lucid Group. ... Dennis. “You need to understand what their current experience is, what their touchpoints are, what happens at those touchpoints and, ultimately, how can you improve
More from news
Approximately 1 fully matching, plus 12 partially matching documents found.
We’re on an evolutionary journey with patient-centricity,” said Dennis O’Brien, CEO, Lucid Group. ... That focus, said Dennis, presents a huge opportunity to broaden the scope of patient- centricity.
Welcome to the world of social media in pharma, 2019-style. The words of Dennis O’Brien, CEO at Lucid Group, provide a mischievous metaphor to which we can all relate: ... The question is: why? Pay to party. Dennis O'Brien. “Pharma isn’t yet
It’s making progress, but there’s a long way to go. “We’ve got to get much closer to patients,” said Dennis O’Brien, CEO, Lucid Group. ... We need to get over it.”. Progress, said Dennis, may require a fundamental shift in mindset.
Pharma widely accepts that it struggles to measure digital marketing effectiveness – but perhaps it’s starting from the wrong place,” said Dennis O’Brien, CEO, Lucid Group. ... said Dennis O’Brien.
compliance against regulation in the core areas where pharma has tripped up in the past, says Dennis O’Brien, CEO, Lucid Group.
More from intelligence
Approximately 0 fully matching, plus 17 partially matching documents found.
His balance of commercial strategy, business and people focus make him a perfect fit for Lucid as he leads a core part of our business,” said Dennis O’Brien, Lucid Group
Dennis O’Brien, CEO and co-founder of Lucid, said: “Andy is a great fit with the team – and his history and experience in US and global pharma communications, both agency
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Dennis O’Brien commented, “We are committed to building an industry-leading healthcare communications business that delivers life-transforming value to everyone, globally.
Dennis O’Brien, Lucid Group CEO, commented, “We are excited to welcome Laurence to the organisation.
Dennis O’Brien, Lucid Group CEO commented, “I’ve had the pleasure of seeing Ify grow and develop as a person and a colleague.
Dennis O'Brien, Lucid Group CEO and co-founder commented, “After thirteen years we continue to drive an exciting organisation forward.
Neil will report to Dennis O’Brien, Lucid Group CEO, and sit on the Group’s Executive Committee. ... Dennis commented, “Neil is an exceptional communications professional and a talent we have admired for some time.
More from PMHub
Approximately 0 fully matching, plus 40 partially matching documents found.
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....